Griffin Michelle Renee
SEC-identified person · CIK 1229765 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Director | filed 2019–2026 |
| Chinook Therapeutics, INC. KDNY | Director | filed 2020–2023 |
| Pharmafrontiers Corp. pftr.ob | Director | filed 2017–2023 |
| HTG Molecular Diagnostics, INC HTGM | Director | filed 2018–2022 |
| Phaserx, INC. PZRX | Director | filed 2016–2017 |
| Sonus Pharmaceuticals INC ogxi | Director · CFO | filed 2006–2012 |
| Trubion Pharmaceuticals, Inc TRBN | Senior V.P. and C.O.O. | filed 2006–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.